inclusion criteria: participant must be able to understand and provide informed consent no evidence of infectious illness (defined as fever >38 degrees celsius, vomiting, diarrhea, new cough, new shortness of breath, new congestion, new runny nose, new headache or sore throat) within 14 days of vaccine administration. participant must have a history of adverse reaction to either the pfizer-biontech mrna covid vaccination or the moderna mrna covid vaccination or have a personal history of allergic reaction and covid vaccination avoidance. females of childbearing potential must have a negative pregnancy test prior to vaccination.

inclusion criteria: participant must be able to understand and provide informed consent no evidence of infectious illness (defined as fever >38 degrees celsius, vomiting, diarrhea, new cough, new shortness of breath, new congestion, new runny nose, new headache or sore throat) within 14 days of vaccine administration. participant must have a history of adverse reaction to either the pfizer-biontech mrna covid vaccination or the moderna mrna covid vaccination or have a personal history of allergic reaction and covid vaccination avoidance. females of childbearing potential must have a negative pregnancy test prior to vaccination.

inclusion criteria: participant must be able to understand and provide informed consent no evidence of infectious illness (defined as fever >38 degrees celsius, vomiting, diarrhea, new cough, new shortness of breath, new congestion, new runny nose, new headache or sore throat) within 14 days of vaccine administration. participant must have a history of adverse reaction to either the pfizer-biontech mrna covid vaccination or the moderna mrna covid vaccination within the past 3 months. females of childbearing potential must have a negative pregnancy test prior to vaccination.

inclusion criteria: participant must be able to understand and provide informed consent no evidence of infectious illness (defined as fever >38 degrees celsius, vomiting, diarrhea, new cough, new shortness of breath, new congestion, new runny nose, new headache or sore throat) within 14 days of vaccine administration. participant must have a history of adverse reaction to either the pfizer-biontech mrna covid vaccination or the moderna mrna covid vaccination within the past 3 months. females of childbearing potential must have a negative pregnancy test prior to vaccination.

inclusion criteria: participant must be able to understand and provide informed consent no evidence of infectious illness (defined as fever >38 degrees celsius, vomiting, diarrhea, new cough, new shortness of breath, new congestion, new runny nose, new headache or sore throat) within 14 days of vaccine administration. participant must have a history of adverse reaction to the pfizer-biontech mrna covid vaccination within the past 3 months. females of childbearing potential must have a negative pregnancy test prior to vaccination.

inclusion criteria: participant must be able to understand and provide informed consent no evidence of infectious illness (defined as fever >38 degrees celsius, vomiting, diarrhea, new cough, new shortness of breath, new congestion, new runny nose, new headache or sore throat) within 14 days of vaccine administration. participant must have a history of adverse reaction to the pfizer-biontech mrna covid vaccination within the past 3 months. females of childbearing potential must have a negative pregnancy test prior to vaccination.